Detalles de la búsqueda
1.
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol;
20(2): 282-296, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30665869
2.
Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer.
Oncologist;
22(3): 293-303, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28209749
3.
Attitudes toward participating in Phase I clinical trials: an investigation with patient-family-physician triads.
Jpn J Clin Oncol;
46(12): 1095-1101, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27677660
4.
Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy: results of an exploratory study in patients with acute myeloid leukemia.
Support Care Cancer;
24(1): 187-194, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25980681
5.
Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer.
Oncologist;
20(8): 896-7, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26112004
6.
A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patients.
Support Care Cancer;
23(6): 1769-77, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25465680
7.
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
Lancet Oncol;
15(12): 1389-96, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25439693
8.
Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy.
Cancer Sci;
105(12): 1569-75, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25263825
9.
A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer.
Invest New Drugs;
32(3): 561-8, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24573743
10.
Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors.
Invest New Drugs;
32(6): 1311-5, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25146938
11.
Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer.
Tumour Biol;
35(6): 5735-40, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24737581
12.
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.
BMC Cancer;
14: 883, 2014 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424120
13.
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial.
Lancet Oncol;
14(11): 1077-1085, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24028813
14.
Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant;
19(6): 994-9, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23571460
15.
Prognostic role of serum lactate dehydrogenase beyond initial diagnosis: a retrospective analysis of patients with diffuse large B cell lymphoma.
Acta Haematol;
130(4): 305-11, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24008775
16.
Bone marrow involvement is predictive of infusion-related reaction during rituximab administration in patients with B cell lymphoma.
Support Care Cancer;
21(4): 1145-52, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23111943
17.
Neoadjuvant treatment of mid-to-lower rectal cancer with oxaliplatin plus 5-fluorouracil and leucovorin in combination with radiotherapy: a Korean single center phase II study.
Int J Clin Oncol;
18(2): 260-6, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22350021
18.
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
Lancet Oncol;
13(2): 181-8, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22192731
19.
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.
Lancet Oncol;
13(11): 1125-32, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23062232
20.
Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE).
Cancer Med;
12(7): 7784-7794, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36515003